Surescripts Expands Prior Authorization Automation: Slashing Prescription Approval Times as New CMS Interoperability Rules Loom

Why It Matters

Accelerating prior‑authorization approvals cuts administrative friction, improves medication access, and reduces costs for patients, positioning Surescripts as a pivotal enabler of the CMS‑driven interoperability agenda.

Key Takeaways

• 68,000 prescribers now use Surescripts automation, up 50% since Dec 2025
• Median prior‑authorization approval time dropped to 18 seconds
• Real‑time benefit tool saved patients $19.7 million Jan‑Apr 2026
• Automation reduced missing‑information denials by 11% and appeals by 17%
• CMS Interoperability rule expected to accelerate point‑of‑care tool adoption

Pulse Analysis

The traditional prior‑authorization process has long been a bottleneck, forcing clinicians to juggle paper forms, faxes, and phone calls that delay treatment. Surescripts’ expanded automation embeds directly into electronic health‑record e‑prescribing flows, pulling required clinical data and matching it against payer criteria in real time. By routing approvals through a secure network, the platform now achieves an 18‑second median decision time, dramatically shrinking the administrative lag that historically stretched days or weeks.

Beyond speed, the solution improves data quality and reduces denial rates. Health systems report an 11% drop in denials caused by missing information and a 17% decline in medical appeals, while the platform’s drug coverage has grown to 104 medications, delivering a 34% automated approval rate for in‑scope therapies. Clinicians also benefit from electronic prior‑authorization (ePA) for complex cases, driving a 26% year‑over‑year increase in electronic processing of specialty prescriptions.

Financially, the Real‑Time Prescription Benefit tool shines, delivering $19.7 million in patient savings in just four months of 2026—averaging $817 per specialty script and $77 per standard prescription. This transparency boosts adherence, with studies showing a 3.4% rise in medication compliance among diabetic patients using the tool. As CMS prepares to enforce its Interoperability and Prior Authorization rule (CMS‑0062‑P), adoption of Surescripts’ point‑of‑care capabilities is poised to accelerate, reshaping the prescription ecosystem toward faster, cheaper, and more patient‑centered care.